Studies on the mechanism of action of the aptamer BAX499, an Inhibitor of tissue factor pathway inhibitor

Thrombosis Research

Volumn 130, Issue 3, 2012, Pages

  Chang, Jen Yea ^a   Chantrathammachart, Pichika ^a   Monroe, Dougald M ^a   Key, Nigel S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Aptamer; TFPI

Indexed keywords

BAX 499; BLOOD CLOTTING FACTOR 10A; RECOMBINANT TISSUE FACTOR PATHWAY INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING TIME; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME KINETICS; HEMOPHILIA A; HUMAN; PRIORITY JOURNAL; PROTHROMBIN TIME;

APTAMERS, NUCLEOTIDE; BLOOD COAGULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FACTOR XA; HEMOPHILIA A; HUMANS; LIPOPROTEINS; PROTHROMBIN TIME;

EID: 84865205051     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.05.010     Document Type: Article

References (27)

1. H.R. Roberts, and A.H. Tabares Overview of the coagulation reactions K.A. High, H.R. Roberts, Molecular Basis of Thrombosis and Hemostasis 1995 Marcel Dekker New York 35 50
2. I. Hrachovinová, B. Cambien, A. Hafezi-Moghadam, J. Kappelmayer, R.T. Camphausen, and A. Widom Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A Nat Med 9 2003 1020 1025
3. E. Erhardtsen, M. Ezban, M.T. Madsen, V. Diness, S. Glazer, and U. Hedner Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia A Blood Coagul Fibrinolysis 6 1995 388 394
4. S.A. Maroney, B.C. Cooley, J.P. Ferrel, C.E. Bonesho, L.V. Nielsen, and P.B. Johansen Absence of hematopoietic tissue factor pathway inhibitor mitigates bleeding in mice with hemophilia Proc Natl Acad Sci U S A 109 2012 3927 3931
5. T.J. Girard, L.A. Warren, W.F. Novotny, K.M. Likert, S.G. Brown, and J.P. Miletich Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor Nature 338 1989 518 520
6. T.M. Hackeng, K.M. Seré, G. Tans, and J. Rosing Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor Proc Natl Acad Sci U S A 103 2006 3106 3111
7. T. Liu, C.D. Scallan, G.J. Broze Jr., S. Patarroyo-White, G.F. Pierce, and K.W. Johnson Improved coagulation in bleeding disorders by Non-Anticoagulant Sulfated Polysaccharides (NASP) Thromb Haemost 95 2006 68 76
8. S. Prasad, D. Lillicrap, A. Labelle, S. Knappe, T. Keller, and E. Burnett Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia A Blood 111 2008 672 679
9. P.-S. Zheng, M. Reis, C. Sparling, D.Y. Lee, D.P. La Pierre, and C.-K.A. Wong Versican G3 domain promotes blood coagulation through suppressing the activity of tissue factor pathway inhibitor-1 J Biol Chem 281 2006 8175 8182
10. A.H. Pedersen, O. Nordfang, F. Norris, F.C. Wiberg, P.M. Christensen, and K.B. Moeller Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions J Biol Chem 265 1990 16786 16793
11. L.D. Mayer, M.J. Hope, and P.R. Cullis Vesicles of variable sizes produced by a rapid extrusion procedure Biochim Biophys Acta 858 1986 161 168
12. E.K. Waters, R.M. Genga, M.C. Schwartz, J.A. Nelson, R.G. Schaub, and K.A. Olson Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor Blood 117 2011 5514 5522
13. M.J. Griffith, L. Breitkreutz, H. Trapp, E. Briet, C.M. Noyes, and R.L. Lundblad Characterization of the clotting activities of structurally different forms of activated factor IX. Enzymatic properties of normal human factor IXa alpha, factor IXa beta, and activated factor IX Chapel Hill J Clin Invest 75 1985 4 10
14. R. Wesselschmidt, K. Likert, T. Girard, T.C. Wun, and G.J. Broze Jr. Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa Blood 79 1992 2004 2010
15. Z.F. Huang, T.C. Wun, and G.J. Broze Jr. Kinetics of factor Xa inhibition by tissue factor pathway inhibitor J Biol Chem 268 1993 26950 26955
16. J. Franssen, I. Salemink, G.M. Willems, T.C. Wun, H.C. Hemker, and T. Lindhout Prothrombinase is protected from inactivation by tissue factor pathway inhibitor: competition between prothrombin and inhibitor Biochem J 323 Pt 1 1997 33 37
17. S. Hoops, S. Sahle, R. Gauges, C. Lee, J. Pahle, and N. Simus COPASI-a COmplex PAthway SImulator Bioinformatics 22 2006 3067 3074
18. M.F. Hockin, K.C. Jones, S.J. Everse, and K.G. Mann A model for the stoichiometric regulation of blood coagulation J Biol Chem 277 2002 18322 18333
19. T. Lindhout, J. Franssen, and G. Willems Kinetics of the inhibition of tissue factor-factor VIIa by tissue factor pathway inhibitor Thromb Haemost 74 1995 910 915
20. R.J. Baugh, G.J. Broze Jr., and S. Krishnaswamy Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor J Biol Chem 273 1998 4378 4386
21. A.D. Keefe, S. Pai, and A. Ellington Aptamers as therapeutics Nat Rev Drug Discov 9 2010 537 550
22. J.I. Venäläinen, R.O. Juvonen, J.A. Garcia-Horsman, E.A.A. Wallén, J.A.M. Christiaans, and E.M. Jarho Slow-binding inhibitors of prolyl oligopeptidase with different functional groups at the P1 site Biochem J 382 2004 1003 1008
23. Z.F. Huang, D. Higuchi, N. Lasky, and G.J. Broze Jr. Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice Blood 90 1997 944 951
24. A.E. Mast, and G.J. Broze Jr. Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase Blood 87 1996 1845 1850
25. R. Biggs, and R.G. MacFarlane The reaction of haemophilic plasma to thromboplastin J Clin Pathol 4 1951 445 459
26. R.D. Langdell, R.H. Wagner, and K.M. Brinkhous Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure J Lab Clin Med 41 1953 637 647
27. C. van't Veer, and K.G. Mann Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II J Biol Chem 272 1997 4367 4377